Molecular Testing in Advanced NSCLC
Benjamin Levy, MD, discusses the role of molecular testing in patients with advanced NSCLC.
Stay updated with breaking news from Nsclc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Benjamin Levy, MD, discusses the role of molecular testing in patients with advanced NSCLC.
Patients with advanced NSCLC who received optimal first-line treatment based on biomarker testing demonstrated better outcomes, new findings showed.
Patients with metastatic cancer are increasingly starting immunotherapy within a month prior to death, new data show.
Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control in patients with NSCLC.
Click here to read this study in JAMA Network Open. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine,